Surveillance of HCC Patients after Liver RFA: Role of MRI with Hepatospecific Contrast versus Three-Phase CT Scan—Experience of High Volume Oncologic Institute

<table>77-year-old man treated with RFA for HCC. (a) Arterial-phase, coronal Vibe T1-W FS at 1-month followup. Residual tumor tissue in the cephalad portion of the treated area. (b) Coronal reformatted, artery-phase CT at 1-month followup. Residual tumor tissue in the cephalad portion of the treated area.</table>

Gastroenterology Research and Practice

fig1

Figure 1

Figure 1: Surveillance of HCC Patients after Liver RFA: Role of MRI with Hepatospecific Contrast versus Three-Phase CT Scan—Experience of High Volume Oncologic Institute 

Figure 1 | Surveillance of HCC Patients after Liver RFA: Role of MRI with Hepatospecific Contrast versus Three-Phase CT Scan—Experience of High Volume Oncologic Institute 